Trial Profile
Screening, Efficacy, and Safety Study Evaluating OROS (Methylphenidate HCl), Ritalin and Placebo in Children With ADHD
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Jul 2007
Price :
$35
*
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Sponsors ALZA Corporation
- 24 Nov 2006 New trial record.